Insmed Inc (INSM)
69.86
-0.09
(-0.13%)
USD |
NASDAQ |
Jan 03, 16:00
72.50
+2.64
(+3.78%)
After-Hours: 05:49
Insmed Research and Development Expense (Annual): 571.01M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alnylam Pharmaceuticals Inc | 1.004B |
| Cytokinetics Inc | -- |
| Amicus Therapeutics Inc | 152.38M |
| Ocugen Inc | 39.57M |
| Krystal Biotech Inc | 46.43M |